Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
HALOZYME THERAPEUTICS, INC. (HALO)
|
|
| Credit Analysis |
|
|
|
|
Annual | Quarterly |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Short-term debt | 89.4 | 397.2 | 19.5 | 91.5 | 77.2 | 17.4 | 21.9 | |
| Long-term debt | 1,663.9 | | 383.0 | 34.9 | 125.1 | 199.2 | 28.0 | 49.9 |
| Total debt | 1,753.3 | 397.2 | 402.6 | 126.4 | 202.4 | 216.6 | 49.8 | 49.9 |
| Net debt | 1,012.4 | 29.2 | | | | 11.6 | | |
| |
| Debt to EBITDA | 6.3 | 2.7 | | | 2.4 | | | |
| Net debt to EBITDA | 3.6 | 0.2 | | | | | | |
| |
| EBITDA interest coverage | 37.1 | 7.2 | | | 3.8 | | | |
| EBIT interest coverage | 36.7 | 7.1 | | | 3.7 | | | |
|